The assessment of vascular risk in men with erectile dysfunction: The role of the cardiologist and general physician

International Journal of Clinical Practice

Volumn 67, Issue 11, 2013, Pages 1163-1172

  Jackson, G ^a   Nehra, A ^b   Miner, M ^c   Billups, K L ^d,e   Burnett, A L ^e   Buvat, J ^f   Carson, C C ^g   Cunningham, G ^h   Goldstein, I ⁱ   Guay, A T ^j,k   Hackett, G ^l,m   Kloner, R A ⁿ   Kostis, J B ^o   Montorsi, P ^p   Ramsey, M ^q   Rosen, R ^r   Sadovsky, R ^s   Seftel, A D ^t   Shabsigh, R ^u,v   Vlachopoulos, C ^w   Wu, F C W ^x   more..

^a Guys Kings and St Thomas Dental Institute   (United Kingdom)

^b MAYO CLINIC   (United States)

^c BROWN UNIVERSITY   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e JOHNS HOPKINS HOSPITAL   (United States)

^f Centre d'Etude et de Traitement de la Pathologie de l'Appareil Reproducteur et de la Psychosomatique   (France)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^h ST LUKE S EPISCOPAL HOSPITAL   (United States)

ⁱ ALVARADO HOSPITAL   (United States)

^j Lahey Clinic Medical Center North Shore   (United States)

^k TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^m GOOD SAMARITAN HOSPITAL   (United States)

ⁿ UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^o ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^p CENTRO CARDIOLOGICO MONZINO   (Italy)

^q Clinical Content and Editorial Services   (United States)

^r NEW ENGLAND RESEARCH INSTITUTES   (United States)

^s SUNY DOWNSTATE MEDICAL CENTER   (United States)

^t Division of Female Pelvic Medicine and Reconstructive Surgery   (United States)

^u MAIMONIDES MEDICAL CENTER   (United States)

^v WEILL CORNELL MEDICAL COLLEGE   (United States)

^w UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^x UNIVERSITY OF MANCHESTER   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; CREATININE; GLUCOSE; TESTOSTERONE;

ABDOMINAL OBESITY; ANDROGEN THERAPY; CARDIOLOGIST; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLAUDICATION; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DISEASE DURATION; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; ERECTILE DYSFUNCTION; FAMILY HISTORY; GENERAL PRACTITIONER; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; ISCHEMIC HEART DISEASE; LIFESTYLE; METABOLIC SYNDROME X; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; TRANSIENT ISCHEMIC ATTACK;

ADULT; CARDIOLOGY; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; ERECTILE DYSFUNCTION; GENERAL PRACTICE; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN'S ROLE; RISK ASSESSMENT; RISK REDUCTION BEHAVIOR;

EID: 84886724717     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/ijcp.12200     Document Type: Review

References (102)

1. Hatzimouratidis K, Amar E, Eardley I, et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol 2010; 57: 804-14.
2. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54-61.
3. Giuliano FA, Leriche A, Jaudinot EO, de Gendre AS,. Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both. Urology 2004; 64: 1196-201.
4. Jackson G,. Prevention of cardiovascular disease by the early identification of erectile dysfunction. Int J Impot Res 2008; 20: S9-14.
5. Wu FC, von Eckardstein A,. Androgens and coronary artery disease. Endocr Rev 2003; 24: 183-217.
6. Corona G, Rastrelli G, Monami M, et al. Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. Eur J Endocrinol 2011; 165: 687-701.
7. Ruige JB, Mahmoud AM, De Bacquer D, Kaufman JM,. Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis. Heart 2011; 97: 870-5.
8. Buvat J, Maggi M, Gooren L, et al. Endocrine aspects of male sexual dysfunctions. J Sex Med 2010; 7: 1627-56.
9. Kharbanda RK, Deanfield JE,. Functions of the healthy endothelium. Coron Artery Dis 2001; 12: 485-91.
10. Ganz P, Vita JA,. Testing endothelial vasomotor function: nitric oxide, a multipotent molecule. Circulation 2003; 108: 2049-53.
11. Kirby M, Jackson G, Simonsen U,. Endothelial dysfunction links erectile dysfunction to heart disease. Int J Clin Pract 2005; 59: 225-9.
12. Rubinshtein R, Kuvin JT, Soffler M, et al. Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J 2010; 31: 1142-8.
13. Kitta Y, Obata JE, Nakamura T, et al. Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease. J Am Coll Cardiol 2009; 53: 323-30.
14. Yeboah J, Crouse JR, Hsu FC, et al. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation 2007; 115: 2390-7.
15. Bivalacqua TJ, Usta MF, Champion HC, et al. Endothelial dysfunction in erectile dysfunction: role of the endothelium in erectile physiology and disease. J Androl 2003; 24: S17-37.
16. Francavilla S, Bocchio M, Pelliccione F, et al. Vascular aetiology of erectile dysfunction. Int J Androl 2005; 28 (Suppl. 2): 35-9.
17. Montorsi P, Ravagnani PM, Galli S, et al. Association between erectile dysfunction and coronary artery disease: matching the right target with the right test in the right patient. Eur Urol 2006; 50: 721-31.
18. Corona G, Fagioli G, Mannucci E, et al. Penile doppler ultrasound in patients with erectile dysfunction (ED): role of peak systolic velocity measured in the flaccid state in predicting arteriogenic ED and silent coronary artery disease. J Sex Med 2008; 5: 2623-34.
19. Corona G, Monami M, Boddi V, et al. Male sexuality and cardiovascular risk. A cohort study in patients with erectile dysfunction. J Sex Med 2010; 7: 1918-27.
20. Kaiser DR, Billups K, Mason C, et al. Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J Am Coll Cardiol 2004; 43: 179-84.
21. Esposito K, Ciotola M, Giugliano F, et al. Endothelial microparticles correlate with erectile dysfunction in diabetic men. Int J Impot Res 2007; 19: 161-6.
22. De Angelis L, Marfella MA, Siniscalchi M, et al. Erectile and endothelial dysfunction in type II diabetes: a possible link. Diabetologia 2001; 44: 1155-60.
23. Bocchio M, Desideri G, Scarpelli P, et al. Endothelial cell activation in men with erectile dysfunction without cardiovascular risk factors and overt vascular damage. J Urol 2004; 171: 1601-4.
24. Vlachopoulos C, Aznaouridis K, Ioakeimidis N, et al. Unfavourable endothelial and inflammatory state in erectile dysfunction patients with or without coronary artery disease. Eur Heart J 2006; 27: 2640-8.
25. Vlachopoulos C, Ioakeimidis N, Terentes-Printzios D, Stefanadis C,. The triad: erectile dysfunction-endothelial dysfunction-cardiovascular disease. Curr Pharm Des 2008; 14: 3700-14.
26. Solomon H, Man JW, Wierzbicki AS, Jackson G,. Relation of erectile dysfunction to angiographic coronary artery disease. Am J Cardiol 2003; 91: 230-1.
27. Burchardt M, Burchardt T, Baer L, et al. Hypertension is associated with severe erectile dysfunction. J Urol 2000; 164: 1188-91.
28. Garcia-Malpartida K, Marmol R, Jover A, et al. Relationship between erectile dysfunction and silent myocardial ischemia in type 2 diabetic patients with no known macrovascular complications. J Sex Med 2011; 8: 2606-16.
29. Bohm M, Baumhakel M, Teo K, et al. Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials. Circulation 2010; 121: 1439-46.
30. Schouten BW, Bohnen AM, Bosch JL, et al. Erectile dysfunction prospectively associated with cardiovascular disease in the Dutch general population: results from the Krimpen Study. Int J Impot Res 2008; 20: 92-9.
31. Araujo AB, Hall SA, Ganz P, et al. Does erectile dysfunction contribute to cardiovascular disease risk prediction beyond the Framingham risk score? J Am Coll Cardiol 2010; 55: 350-6.
32. Batty GD, Li Q, Czernichow S, et al. Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial. J Am Coll Cardiol 2010; 56: 1908-13.
33. Blumentals WA, Gomez-Caminero A, Joo S, Vannappagari V,. Should erectile dysfunction be considered as a marker for acute myocardial infarction? Results from a retrospective cohort study. Int J Impot Res 2004; 16: 350-3.
34. Gazzaruso C, Solerte SB, Pujia A, et al. Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors. J Am Coll Cardiol 2008; 51: 2040-4.
35. Montorsi P, Ravagnani PM, Galli S, et al. Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial. Eur Heart J 2006; 27: 2632-9.
36. Ponholzer A, Temml C, Obermayr R, et al. Is erectile dysfunction an indicator for increased risk of coronary heart disease and stroke? Eur Urol 2005; 48: 512-8; discussion 7-8.
37. Salem S, Abdi S, Mehrsai A, et al. Erectile dysfunction severity as a risk predictor for coronary artery disease. J Sex Med 2009; 6: 3425-32.
38. Vlachopoulos C, Rokkas K, Ioakeimidis N, et al. Prevalence of asymptomatic coronary artery disease in men with vasculogenic erectile dysfunction: a prospective angiographic study. Eur Urol 2005; 48: 996-1002; discussion 3.
39. Polonsky TS, Taillon LA, Sheth H, et al. The association between erectile dysfunction and peripheral arterial disease as determined by screening ankle-brachial index testing. Atherosclerosis 2009; 207: 440-4.
40. Montorsi P, Ravagnani PM, Galli S, et al. The artery size hypothesis: a macrovascular link between erectile dysfunction and coronary artery disease. Am J Cardiol 2005; 96: 19M-23M.
41. Fischer A, Gutstein DE, Fayad ZA, Fuster V,. Predicting plaque rupture: enhancing diagnosis and clinical decision-making in coronary artery disease. Vasc Med 2000; 5: 163-72.
42. Araujo AB, Travison TG, Ganz P, et al. Erectile dysfunction and mortality. J Sex Med 2009; 6: 2445-54.
43. Thompson IM, Tangen CM, Goodman PJ, et al. Erectile dysfunction and subsequent cardiovascular disease. JAMA 2005; 294: 2996-3002.
44. Dong JY, Zhang YH, Qin LQ,. Erectile dysfunction and risk of cardiovascular disease meta-analysis of prospective cohort studies. J Am Coll Cardiol 2011; 58: 1378-85.
45. Inman BA, Sauver JL, Jacobson DJ, et al. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc 2009; 84: 108-13.
46. Chew KK, Finn J, Stuckey B, et al. Erectile dysfunction as a predictor for subsequent atherosclerotic cardiovascular events: findings from a linked-data study. J Sex Med 2010; 7: 192-202.
47. Riedner CE, Rhoden EL, Fuchs SC, et al. Erectile dysfunction and coronary artery disease: an association of higher risk in younger men. J Sex Med 2011; 8: 1445-53.
48. Montorsi F, Briganti A, Salonia A, et al. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol 2003; 44: 360-4
49. Baumhakel M, Bohm M,. Erectile dysfunction correlates with left ventricular function and precedes cardiovascular events in cardiovascular high-risk patients. Int J Clin Pract 2007; 61: 361-6.
50. Hodges LD, Kirby M, Solanki J, et al. The temporal relationship between erectile dysfunction and cardiovascular disease. Int J Clin Pract 2007; 61: 2019-25.
51. Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-421.
52. Collins GS, Altman DG,. An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study. BMJ 2009; 339: b2584.
53. Perk J, De Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2012; 33: 1635-701.
54. Greenstein A, Chen J, Miller H, et al. Does severity of ischemic coronary disease correlate with erectile function? Int J Impot Res 1997; 9: 123-6.
55. Goglia L, Tosi V, Sanchez AM, et al. Endothelial regulation of eNOS, PAI-1 and t-PA by testosterone and dihydrotestosterone in vitro and in vivo. Mol Hum Reprod 2010; 16: 761-9.
56. Traish AM, Park K, Dhir V, et al. Effects of castration and androgen replacement on erectile function in a rabbit model. Endocrinology 1999; 140: 1861-8.
57. Morelli A, Filippi S, Mancina R, et al. Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa. Endocrinology 2004; 145: 2253-63.
58. Zhang XH, Morelli A, Luconi M, et al. Testosterone regulates PDE5 expression and in vivo responsiveness to tadalafil in rat corpus cavernosum. Eur Urol 2005; 47: 409-16; discussion 16.
59. Guay AT, Velasquez E, Perez JB,. Characterization of patients in a medical endocrine-based center for male sexual dysfunction. Endocr Pract 1999; 5: 314-21.
60. Buvat J, Bou Jaoude G,. Significance of hypogonadism in erectile dysfunction. World J Urol 2006; 24: 657-67.
61. Araujo AB, Dixon JM, Suarez EA, et al. Clinical review: endogenous testosterone and mortality in men: a systematic review and meta-analysis. J Clin Endocrinol Metab 2011; 96: 3007-19.
62. Grossmann M, Thomas MC, Panagiotopoulos S, et al. Low testosterone levels are common and associated with insulin resistance in men with diabetes. J Clin Endocrinol Metab 2008; 93: 1834-40.
63. Laaksonen DE, Niskanen L, Punnonen K, et al. Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol 2003; 149: 601-8.
64. Osuna JA, Gomez-Perez R, Arata-Bellabarba G, Villaroel V,. Relationship between BMI, total testosterone, sex hormone-binding-globulin, leptin, insulin and insulin resistance in obese men. Arch Androl 2006; 52: 355-61.
65. Kapoor D, Aldred H, Clark S, et al. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity. Diabetes Care 2007; 30: 911-7.
66. Jones TH, Arver S, Behre HM, et al. Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study). Diabetes Care 2011; 34: 828-37.
67. Grossmann M,. Low testosterone in men with type 2 diabetes: significance and treatment. J Clin Endocrinol Metab 2011; 96: 2341-53.
68. Shores MM, Smith NL, Forsberg CW, et al. Testosterone treatment and mortality in men with low testosterone levels. J Clin Endocrinol Metab 2012; 97: 2050-58.
69. Hackett G,. Long acting testosterone undecanoate improved ageing male symptom scores but not depression versus placebo in a hypogonadal population with type 2 diabetes. 14th European Society of Sexual Medicine Congress, Milan, Italy, 2011.
70. Buvat J, Montorsi F, Maggi M, et al. Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study). J Sex Med 2011; 8: 284-93.
71. Gazzaruso C, Giordanetti S, De Amici E, et al. Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation 2004; 110: 22-6.
72. Yeboah J, McClelland RL, Polonsky TS, et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA 2012; 308: 788-95.
73. Gaziano JM, Wilson PW,. Cardiovascular risk assessment in the 21st century. JAMA 2012; 308: 816-7.
74. Vlachopoulos CV, Terentes-Printzios DG, Ioakeimidis NK, et al. Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis of cohort studies. Circ Cardiovasc Qual Outcomes 2013; 6: 99-109.
75. Esposito K, Giugliano F, Di Palo C, et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 2004; 291: 2978-84.
76. Seftel AD, Sun P, Swindle R,. The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction. J Urol 2004; 171: 2341-5.
77. Roumeguere T, Wespes E, Carpentier Y, et al. Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary heart disease risk. Eur Urol 2003; 44: 355-9.
78. Dusing R,. Effect of the angiotensin II antagonist valsartan on sexual function in hypertensive men. Blood Press Suppl 2003; 2: 29-34.
79. Fogari R, Zoppi A, Poletti L, et al. Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study. Am J Hypertens 2001; 14: 27-31.
80. Baumhakel M, Schlimmer N, Bohm M,. Effect of irbesartan on erectile function in patients with hypertension and metabolic syndrome. Int J Impot Res 2008; 20: 493-500.
81. Gokkaya SC, Ozden C, Levent Ozdal O., et al. Effect of correcting serum cholesterol levels on erectile function in patients with vasculogenic erectile dysfunction. Scand J Urol Nephrol 2008; 42: 437-40.
82. Saltzman EA, Guay AT, Jacobson J,. Improvement in erectile function in men with organic erectile dysfunction by correction of elevated cholesterol levels: a clinical observation. J Urol 2004; 172: 255-8.
83. Gupta BP, Murad MH, Clifton MM, et al. The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med 2011; 171: 1797-803.
84. Shores MM, Matsumoto AM, Sloan KL, Kivlahan DR,. Low serum testosterone and mortality in male veterans. Arch Intern Med 2006; 166: 1660-5.
85. Laughlin GA, Barrett-Connor E, Bergstrom J,. Low serum testosterone and mortality in older men. J Clin Endocrinol Metab 2008; 93: 68-75.
86. Khaw KT, Dowsett M, Folkerd E, et al. Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation 2007; 116: 2694-701.
87. Haring R, Volzke H, Steveling A, et al. Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79. Eur Heart J 2010; 31: 1494-501.
88. Malkin CJ, Pugh PJ, Morris PD, et al. Low serum testosterone and increased mortality in men with coronary heart disease. Heart 2010; 96: 1821-5.
89. Tivesten A, Vandenput L, Labrie F, et al. Low serum testosterone and estradiol predict mortality in elderly men. J Clin Endocrinol Metab 2009; 94: 2482-8.
90. Menke A, Guallar E, Rohrmann S, et al. Sex steroid hormone concentrations and risk of death in US men. Am J Epidemiol 2010; 171: 583-92.
91. Vikan T, Schirmer H, Njolstad I, Svartberg J,. Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men: the Tromso Study. Eur J Endocrinol 2009; 161: 435-42.
92. Corona G, Monami M, Boddi V, et al. Low testosterone is associated with an increased risk of MACE lethality in subjects with erectile dysfunction. J Sex Med 2010; 7: 1557-64.
93. Detrano R, Guerci AD, Carr JJ, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 2008; 358: 1336-45.
94. Johnson KM, Dowe DA,. The detection of any coronary calcium outperforms Framingham risk score as a first step in screening for coronary atherosclerosis. AJR Am J Roentgenol 2010; 194: 1235-43.
95. Jackson G, Padley S,. Erectile dysfunction and silent coronary artery disease: abnormal computed tomography coronary angiogram in the presence of normal exercise ECGs. Int J Clin Pract 2008; 62: 973-6.
96. Nambi V, Chambless L, Folsom AR, et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. J Am Coll Cardiol 2010; 55: 1600-7.
97. Vlachopoulos C, Aznaouridis K, Ioakeimidis N, et al. Arterial function and intima-media thickness in hypertensive patients with erectile dysfunction. J Hypertens 2008; 26: 1829-36.
98. Fowkes FG, Murray GD, Butcher I, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008; 300: 197-208.
99. Vlachopoulos C, Aznaouridis K, Stefanadis C,. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010; 55: 1318-27.
100. Ridker PM, Glynn RJ, Hennekens CH,. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998; 97: 2007-11.
101. Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347: 1557-65.
102. Chang ST, Chu CM, Hsu JT, et al. Independent determinants of coronary artery disease in erectile dysfunction patients. J Sex Med 2010; 7: 1478-87.